Relative Content

Merck Keytruda

Merck’s Keytruda helps lung cancer patients live longer in trial

Merck’s cancer drug Keytruda. REUTERS/via Merck April 9, 2018 By Tamara Mathias (Reuters) – Merck & Co’s <MRK.N> blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in the lucrative lung cancer market. Shares of the drugmaker were up 3.1 percent […]